acridines has been researched along with Central Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, H; Haapalinna, A; Holappa, J; Koivisto, A; Kuokkanen, K; Lehtimäki, J; Mijatovic, J; Piepponen, P; Sallinen, J; Sirviö, J; Tanila, H; Virtanen, R | 1 |
| Klerman, GL | 1 |
1 review(s) available for acridines and Central Nervous System Diseases
| Article | Year |
|---|---|
Pharmacotherapy of schizophrenia.
Topics: Acridines; Administration, Oral; Antipsychotic Agents; Butyrophenones; Central Nervous System Diseases; Dopamine; Humans; Molindone; Phenothiazines; Phytotherapy; Piperazines; Plants, Medicinal; Rauwolfia; Schizophrenia; Seizures; Structure-Activity Relationship; Tetrabenazine; Thioxanthenes; Tranquilizing Agents; Vitamin B 12 | 1974 |
1 other study(ies) available for acridines and Central Nervous System Diseases
| Article | Year |
|---|---|
Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
Topics: Acridines; Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents; Benzofurans; Central Nervous System; Central Nervous System Diseases; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Hypothermia; Male; Mice; Neuroprotective Agents; Phencyclidine; Piperazines; Quinolizidines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2 | 2013 |